Glioma Diagnosis 2021: Something old, Something new - Anticipating the new WHO
Diagnosing Barrett's Esophagus: Twists and Turns and Lessons Learned
Advocacy - The Why, What, and How
Evaluation and Feedback for Faculty and Trainees
Facing the Real World - What Graduating Pathologists Need to Know
Unlocking Your Authentic Self
Liver Biopsy Interpretation: Patterns and Clinical Correlations
Cervical Cancer Screening and Management: What's New in Clinical Guidelines
Molecular Biomarker Testing in Advanced Breast Cancer: Current Landscape and Future Directions
Cancer Diagnostics and Precision Medicine
Hereditary Genetic Changes and Somatic Mutations in Precision Oncology
Application of Molecular and Genomic Biomarker Testing in Solid Tumors
Application of Molecular and Genomic Biomarker Testing in Hematopathology (no CME)
Effective Communication and Collaboration Across the Multidisciplinary Team (no CME)
Digital Pathology and AI in Cancer Diagnostics (no CME)
PTEN in Metastatic Prostate Cancer
FSP Precision Medicine Academy Virtual Tumor Board - Moffitt Cancer Center
HER2 Testing in Metastatic Solid Tumors Beyond Breast and Gastric: Navigating an Evolving Landscape
Lung Cancer: updates in lung cancer biomarkers and targeted therapies
Lung Cancer Panel
Digital Pathology and AI: whole slide imaging, computational pathology, and emerging biomarkers
Digital Pathology and AI Panel
Breast Cancer: evolving landscape of breast cancer biomarkers including emerging markers
Breast Cancer Panel
Molecular Residual Disease Testing: Innovations, Clinical Adoption, and the Role of Pathology
Gastric Cancer: access to biomarker testing; processes delays
Head/neck Cancer & PD-L1 testing
Biomarker Diagnostics Panel Discussion (from common to rare cancers)